ClinicalTrials.gg
Not yet recruitingNCT07870486Updated Oct 14, 2026

Effects of Otago Exercise Combined With Short-Foot Exercise in Older Adults

An interventional study of Otago Exercise Programme and Otago Exercise Programme + Short-Foot Exercise in Aging, sponsored by Pamukkale University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-14.

Sponsored by Pamukkale University · Not applicable, Interventional, and Treatment

Updated Oct 14, 2026Eligibility revisedNewly registered+2 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

The Otago Exercise Programme is a multicomponent exercise approach targeting strength, balance, and mobility in older adults. Short-foot exercises are designed to improve intrinsic foot muscle activation and medial longitudinal arch control. This randomized comparative study will investigate whether adding short-foot exercises to the Otago Exercise Programme provides additional benefits in older adults.

Read the detailed description

Age-related changes in sensory processing, proprioception, muscle strength, and postural control may contribute to impaired balance and reduced functional mobility in older adults. The ankle-foot complex plays an important role in postural control by providing mechanical support and sensory information during standing and walking. Changes in ankle proprioception, ankle muscle function, and foot posture may therefore influence balance-related performance in older adults.

The Otago Exercise Programme is a structured, multicomponent exercise approach developed to improve lower extremity strength, balance, and walking ability in older adults. Short-foot exercises specifically target the intrinsic foot muscles and active control of the medial longitudinal arch. The addition of short-foot exercises to a conventional balance and strengthening programme may provide a complementary approach by addressing foot-related neuromuscular control.

In this randomized comparative study, participants will be assigned to either the Otago Exercise Programme alone or the Otago Exercise Programme combined with Short-Foot Exercises. Both interventions will be administered under physiotherapist supervision for 8 weeks, twice weekly. The study will compare the effects of these two exercise approaches and evaluate whether the addition of short-foot exercises provides further benefit beyond the Otago Exercise Programme alone.

02

Conditions studied

  • Aging

Keywords

  • Older Adults
  • Balance
  • Joint Position Sense
  • Muscle Strength
  • Fear of Falling
  • Foot Posture
03

In context

Lead sponsor

Pamukkale University is the lead sponsor of 340 studies on the registry; 62 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Willing to participate and provide written informed consent.
  • Aged 65 years or older.
  • Residing in the nursing home where the study will be conducted for at least 3 months.
  • Able to understand and follow test instructions, with a Standardized Mini-Mental Test score ≥24.
  • Able to walk at least 30 meters without physical assistance from another person.
  • Able to stand with eyes open for at least 30 seconds and safely complete sit-to-stand and balance assessments.
  • Able to perform the target ankle dorsiflexion and plantar flexion angles without pain or marked restriction of active range of motion.
  • Navicular Drop Test result between 6 and 9 mm.

Exclusion criteria

Exclusion Criteria:

  • History of neurological or neurodegenerative disease that may substantially affect postural control, proprioception, or motor responses, including stroke sequelae, Parkinson's disease, multiple sclerosis, advanced dementia, or marked cerebellar disorders.
  • Cardiopulmonary, vestibular, or systemic disease that may prevent safe completion of the interventions or assessments.
  • Diagnosed peripheral neuropathy, marked lower-extremity sensory loss, or diabetic neuropathy.
  • Use of an assistive device.
  • Lower-extremity amputation, prosthesis use, or severe structural deformity interfering with foot or ankle assessment.
  • Pain, instability, or severe range-of-motion limitation in the ankle, knee, or hip that prevents completion of the tests.
  • History of lower-extremity fracture, surgery, or major trauma within the previous 6 months.
  • Musculoskeletal injury of the foot, ankle, or lower extremity within the previous 3 months that limits participation in functional testing.
  • Open wound, ulcer, active skin lesion, or infection in the foot or ankle region that interferes with sensor or measurement placement.
  • Recent initiation of, or dose change in, medication that may affect balance, alertness, or motor performance.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    Otago Exercise Programme

    Participants in this arm will receive a supervised Otago Exercise Programme for 8 weeks, with 2 sessions per week. Each 50-minute session will consist of 5 minutes of warm-up, 40 minutes of Otago exercises, and 5 minutes of cool-down. The Otago component will include lower extremity strengthening, static and dynamic balance exercises, and functional balance and walking tasks. Exercise difficulty will be progressively adjusted according to individual performance and safety.

    Behavioral: Otago Exercise Programme

  • Experimental
    Otago Exercise Programme + Short-Foot Exercise

    Participants in this arm will receive the Otago Exercise Programme combined with Short-Foot Exercises for 8 weeks, with 2 supervised sessions per week. Each 60-minute session will include 5 minutes of warm-up, 10 minutes of Short-Foot Exercises, 40 minutes of Otago exercises, and 5 minutes of cool-down. Short-Foot Exercises will target intrinsic foot muscle activation and medial longitudinal arch control by drawing the first metatarsal head toward the heel without toe flexion. Exercises will progress from sitting to standing, mini-squat, and soft-surface standing. Three blocks of 12 repetitions will be performed, with each contraction held for 5 seconds and 2 minutes of rest between blocks.

    Behavioral: Otago Exercise Programme + Short-Foot Exercise

Interventions

  • BehavioralOtago Exercise Programme

    The Otago Exercise Programme will be delivered under physiotherapist supervision for 8 weeks, 2 days per week, for a total of 16 sessions. Each session will last 50 minutes and will include warm-up, lower extremity strengthening, static and dynamic balance exercises, functional balance and walking tasks, and cool-down. Exercises will be progressively adjusted according to participant performance and safety.

  • BehavioralOtago Exercise Programme + Short-Foot Exercise

    The combined intervention will be delivered under physiotherapist supervision for 8 weeks, 2 days per week, for a total of 16 sessions. Each 60-minute session will include 5 minutes of warm-up, 10 minutes of Short-Foot Exercises, 40 minutes of Otago exercises, and 5 minutes of cool-down. Short-Foot Exercises will target intrinsic foot muscle activation and medial longitudinal arch control and will progress from sitting to standing, mini-squat, and soft-surface standing according to participant performance.

06

What researchers measure

Primary outcomes

  1. Five Times Sit-to-Stand Test (5STS

    Lower-extremity functional capacity will be assessed using the Five Times Sit-to-Stand Test (5STS). Participants will sit on a standard-height chair without armrests, with the arms crossed over the chest, and will be instructed to stand up fully and sit down five consecutive times as quickly as possible. The time from initiation of the first stand to completion of the fifth sitting will be recorded in seconds. Lower completion times indicate better functional performance

    Time frame: Baseline (pre-intervention) and immediately post-intervention (Week 8).

Secondary outcomes

  1. Dynamic Balance - Mini-BESTest

    Dynamic balance will be assessed using the Mini-BESTest, a 14-item clinical balance test evaluating anticipatory postural adjustments, reactive postural control, sensory orientation, and dynamic gait. Each item is scored from 0 to 2, resulting in a total score ranging from 0 to 28. Higher scores indicate better dynamic balance performance.

    Time frame: aseline (pre-intervention) and immediately post-intervention (Week 8).

  2. Ankle Joint Position Sense

    Ankle joint position sense will be assessed using the KFORCE Sens® electrogoniometer at target angles of 10° dorsiflexion and 20° plantar flexion. After passive positioning at the target angle, participants will actively reproduce the target position with eyes closed. Joint position sense error will be calculated as the absolute difference, in degrees, between the target and reproduced angles. Three trials will be performed for each movement direction, and the mean value will be used. Lower error values indicate better joint position sense.

    Time frame: Baseline (pre-intervention) and immediately post-intervention (Week 8).

  3. Ankle Muscle Strength

    Ankle dorsiflexor and plantar flexor muscle strength will be assessed using the JTECH PowerTrack II Commander hand-held dynamometer. Three measurements will be performed for each muscle group, and the mean value will be used for analysis. Higher force values indicate greater muscle strength.

    Time frame: Baseline (pre-intervention) and immediately post-intervention (Week 8).

  4. Falls Efficacy Scale-International (FES-I)

    Fear of falling will be assessed using the Falls Efficacy Scale-International (FES-I). The scale consists of 16 items, each scored from 1 to 4, resulting in a total score ranging from 16 to 64. Higher scores indicate greater concern about falling.

    Time frame: Baseline (pre-intervention) and immediately post-intervention (Week 8).

  5. Navicular Drop Test

    Foot posture will be assessed using the Navicular Drop Test. The vertical distance from the navicular tuberosity to the floor will be measured in a seated subtalar-neutral position and again during relaxed bilateral standing. The difference between the two measurements will be recorded in millimeters as the navicular drop value. Higher values indicate greater medial longitudinal arch collapse and pronation tendency.

    Time frame: Baseline (pre-intervention) and immediately post-intervention (Week 8).

07

Study locations

1 site
  • Horsunlu Nursing Home Care and Rehabilitation Center
    Aydin, Turkey (Türkiye)
08

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for Apr 2027, 6 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 6, 2026
First posted
Oct 13, 2026
StartEst.
Oct 30, 2026
Primary completionEst.
Apr 30, 2027
CompletionEst.
Apr 30, 2027
Last update
Oct 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
1 site added, 1 site removed
Show site
  • Horsunlu Nursing Home Care and Rehabilitation Center · Aydin, Turkey (Türkiye)
Show 1 removed
  • Horsunlu Nursing Home Care and Rehabilitation Center · Sultanhisar, Turkey (Türkiye)
Oct 14, 2026
Also revised
eligibility
Registered
First appeared on the registry
Oct 13, 2026
Show all 2 updates
  1. Oct 14, 2026
    1 site added, 1 site removed
    Show site
    • Horsunlu Nursing Home Care and Rehabilitation Center · Aydin, Turkey (Türkiye)
    Show 1 removed
    • Horsunlu Nursing Home Care and Rehabilitation Center · Sultanhisar, Turkey (Türkiye)
    Eligibility Criteria revised
  2. Oct 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07870486
Responsible party
Tuba CAN AKMAN (Assistant Professor, Pamukkale University) — Principal investigator
First posted
Oct 13, 2026
Start date
Oct 30, 2026 (estimated)
Primary completion
Apr 30, 2027 (estimated)
Completion
Apr 30, 2027 (estimated)
Last update
Oct 14, 2026

Study contacts

Fatma Aksu, MSc
Contact
ftmaks97@gmail.com
+90 256 387 62 10
Müge İçelli Güneş, PhD
Contact
micelli@pau.edu.tr
02582964256
Tuba Can Akman, PhD
principal investigator · Pamukkale University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion